17 alpha-hydroxyprogesterone caproate has been researched along with norethindrone in 12 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (norethindrone) | Trials (norethindrone) | Recent Studies (post-2010) (norethindrone) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 4,295 | 884 | 303 |
| Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | norethindrone (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.808 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.433 | |
| Progesterone receptor | Homo sapiens (human) | 0.0032 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.433 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.0711 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.433 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 4.537 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
| Bruen, JA; Hick, JF; Kurland, LT; Noller, KL; O'Fallon, WM; Resseguie, LJ | 1 |
| Bokhman, IaV; Tkeshelashvili, VT; Vishnevskiĭ, AS | 1 |
| Rodriguez, L; Schindler, C | 1 |
| Pavlovich, T; Schindler, C | 1 |
| Schindler, C | 1 |
| Schindler, C; Schober, J | 1 |
| Sang, GW | 1 |
| Koetsawang, S | 1 |
| Giwa-Osagie, OF | 1 |
4 review(s) available for 17 alpha-hydroxyprogesterone caproate and norethindrone
| Article | Year |
|---|---|
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1994 |
Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Carbohydrate Metabolism; Contraceptive Agents, Female; Estradiol; Female; Hemostasis; Humans; Hydroxyprogesterones; Injections; Lipid Metabolism; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; World Health Organization | 1993 |
8 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and norethindrone
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Ethisterone; Female; Fetal Death; Humans; Hydroxyprogesterones; Infant, Newborn; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Minnesota; Norethindrone; Pregnancy; Prenatal Exposure Delayed Effects; Progesterone; Progestins | 1985 |
[Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Chlormadinone Acetate; Combined Modality Therapy; Contraceptives, Oral, Combined; Dilatation and Curettage; Drug Combinations; Drug Therapy, Combination; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Leiomyoma; Mestranol; Middle Aged; Norethindrone; Time Factors; Uterine Neoplasms | 1984 |
[Comparative studies of the effect on the in vitro growth of endometrial cancers of hydroxyprogesterone caproate, norethisterone acetate and D-norgestrel].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1984 |
[Comparison of the results of gestagen therapy of cancer of the corpus uteri with a preliminary study of tumor cell culture sensitivity to the preparations].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norgestrel; Progesterone Congeners; Uterine Neoplasms | 1982 |
[Use of gestagens to control in vitro growth of endometrial carcinoma (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norgestrel; Progestins; Uterine Neoplasms | 1981 |
[Results obtained from gestagen treatment of patients for endometrial carcinoma, with particular reference to results obtained from in vitro tests before treatment (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Drug Resistance; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1981 |